General Atlantic invests $130 mn in KIMS Hospitals

Hyderabad, Leading global growth equity firm General Atlantic has invested $130 million to acquire minority stake in Krishna Institute of Medical Sciences (KIMS Hospitals), a leading multi-disciplinary provider of healthcare services in Andhra Pradesh and Telangana, it was announced on Wednesday.

KIMS announced that it has received a strategic growth investment from General Atlantic, with the equity firm making the investment, in a combination of primary capital and secondary purchases, to acquire a significant minority stake in the company, said a statement.

Set up in 2004 by Dr. Bhaskar Rao, a renowned cardiothoracic surgeon, KIMS Hospitals has grown to become one of the largest corporate healthcare groups in southern India, with seven multi-specialty hospitals across the region and a capacity of over 2,500 beds.

“We are thrilled to partner with General Atlantic as we embark on our next phase of growth to strengthen our presence in underserved geographies. Given General Atlantic’s deep experience of investing in healthcare globally and its network of relationships across leading global healthcare institutions, we are confident that his new association will help KIMS Hospitals deliver on its goal of bringing quality medical care, modern medical facilities, and services within the reach of the common man,” said Bhaskar Rao, MD and CEO of KIMS Hospitals.

“The combination of an acute shortage in quality healthcare infrastructure and a strong focus from the government to make quality healthcare more accessible, has created compelling secular tailwinds to drive growth for high-quality corporate hospital networks. We believe KIMS Hospitals is uniquely positioned to benefit from these trends,” said Sandeep Naik, Managing Director and Head of India and Asia-Pacific at General Atlantic.

General Atlantic has been active in India since 1999 and has invested over $2 billion in the India and Asia-Pacific region, as of December 31, 2017. It focuses on investments in healthcare, technology, consumer, and financial services.

  • Related Posts

    Galgotia Outrage in AI Expo evokes SOS from Domestic MedTech Industry

    Chinese ‘Made in India’ Fakes brazening out with Impunity in Here too New Delhi: Chinese slur on AI Expo, thanks to Galgotia fiasco, has hit a raw nerve in domestic…

    Innovation & Biomedical Skill Centre (IBSC) is transforming Biomedical & Medical Device Workforce Scenario

    Landmark Industry-Academia Meet in AMTZ Visakhapatnam: Andhra Pradesh MedTech Zone (AMTZ), India’s leading MedTech ecosystem, hosted a landmark Industry–Academia Meet to commemorate eight transformative years of the Innovation and Biomedical…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Medical Negligence and Quackery Rampant: 9-Year-Old Dies from Wrong Injection, Pregnant Woman Succumbs to Quack Treatment, Raids Uncover Illegal Practices Across MP, Haryana, UP & Chhattisgarh

    Medical Negligence and Quackery Rampant: 9-Year-Old Dies from Wrong Injection, Pregnant Woman Succumbs to Quack Treatment, Raids Uncover Illegal Practices Across MP, Haryana, UP & Chhattisgarh

    Drug Diversion Epidemic Sweeps India: Absence of Track-and-Trace System, overly Codeine Allotments, and Regulatory Apathy Fuel Misuse of Narcotic Syrups and Tablets

    Drug Diversion Epidemic Sweeps India: Absence of Track-and-Trace System, overly Codeine Allotments, and Regulatory Apathy Fuel Misuse of Narcotic Syrups and Tablets

    Multi-State Supply Chain of Fake RituxiRel and Alburel Injections Exposed Amid Health Risks

    Multi-State Supply Chain of Fake RituxiRel and Alburel Injections Exposed Amid Health Risks

    TN, Karnataka, Rajasthan declare highest number of NSQs in January

    TN, Karnataka, Rajasthan declare highest number of NSQs in January

    Centre reorganises CDSCO Zone Baddi amid Drug Quality Concerns

    Centre reorganises CDSCO Zone Baddi amid Drug Quality Concerns

    CDSCO modifies norms for testing permissions to speed up drug approvals

    CDSCO modifies norms for testing permissions to speed up drug approvals